Kalaris Therapeutics, Inc 10-K for FY2021
Kalaris Therapeutics, Inc. (KLRS)
10-K
2022-02-10
For: 2021-12-31
View Original
Added on
April 08, 2026
About this 10-K
Kalaris Therapeutics, Inc filed this 10-K on February 10, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $171.96M
- compared with a net loss of $69.78M a year earlier